Azaline | CAS#134457-26-4 | Gonadorelin antagonist

MedKoo Cat#: 598800 | Name: Azaline

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Azaline is a gonadorelin antagonist.

Chemical Structure

Azaline

CAS#134457-26-4

Theoretical Analysis

MedKoo Cat#: 598800

Name: Azaline

CAS#: 134457-26-4

Chemical Formula: C74H106ClN23O12

Exact Mass: 1543.8080

Molecular Weight: 1545.26

Elemental Analysis: C, 57.52; H, 6.91; Cl, 2.29; N, 20.85; O, 12.42

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.

Bulk Inquiry

Related CAS #

No Data

Synonym

Azaline; Azaline A;

IUPAC/Chemical Name

(S)-N-((2R,4S,7R)-7-acetamido-2-amino-4-((N6-(5-amino-1H-1,2,4-triazol-3-yl)-D-lysyl-L-leucyl)(N6-(5-amino-1H-1,2,4-triazol-3-yl)-L-lysyl)carbamoyl)-1-(4-chlorophenyl)-8-(naphthalen-2-yl)-3,6-dioxooctan-4-yl)-N-(((R)-2-amino-3-(pyridin-3-yl)propanoyl)-L-seryl)-1-(N6-isopropyl-L-lysyl)pyrrolidine-2-carboxamide

InChi Key

XHCGTVHIQUXPRM-SSIREWOPSA-N

InChi Code

1S/C74H106ClN23O12/c1-42(2)34-57(88-62(103)51(76)19-8-12-31-85-72-90-70(81)92-94-72)66(107)97(65(106)53(78)21-10-13-32-86-73-91-71(82)93-95-73)69(110)74(61(102)54(79)36-45-24-27-50(75)28-25-45,39-60(101)56(87-44(5)100)38-46-23-26-48-17-6-7-18-49(48)35-46)98(67(108)58(41-99)89-63(104)55(80)37-47-16-14-29-83-40-47)68(109)59-22-15-33-96(59)64(105)52(77)20-9-11-30-84-43(3)4/h6-7,14,16-18,23-29,35,40,42-43,51-59,84,99H,8-13,15,19-22,30-34,36-39,41,76-80H2,1-5H3,(H,87,100)(H,88,103)(H,89,104)(H4,81,85,90,92,94)(H4,82,86,91,93,95)/t51-,52+,53+,54-,55-,56-,57+,58+,59+,74+/m1/s1

SMILES Code

CC(C[C@H](NC([C@H](N)CCCCNc1n[nH]c(N)n1)=O)C(N(C([C@](C([C@H](N)Cc2ccc(Cl)cc2)=O)(N(C([C@@H](NC([C@H]CC(C)C[C@@H](C(=O)N(C(=O)[C@H](CCCCNC1=NNC(=N1)N)N)C(=O)[C@](CC(=O)[C@@H](CC2=CC3=CC=CC=C3C=C2)NC(=O)C)(C(=O)[C@@H](CC4=CC=C(C=C4)Cl)N)N(C(=O)[C@@H]5CCCN5C(=O)[C@H](CCCCNC(C)C)N)C(=O)[C@H](CO)NC(=O)[C@@H](CC6=CN=CC=C6)N)NC(=O)[C@@H](CCCCNC7=NNC(=N7)N)N

Appearance

Solid powder

Purity

>98% (or refer to the Certificate of Analysis)

Shipping Condition

Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition

Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility

Soluble in DMSO

Shelf Life

>3 years if stored properly

Drug Formulation

This drug may be formulated in DMSO

Stock Solution Storage

0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code

2934.99.03.00

More Info

Instruction

View handling instruction

Preparing Stock Solutions

The following data is based on the product molecular weight 1,545.26 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

1: Ballantyne K, Anderson ST, Pyne M, Nicolson V, Mucci A, Lisle A, Johnston SD. Use of the gonadotrophin-releasing hormone antagonist azaline B to control the oestrous cycle in the koala (Phascolarctos cinereus). Reprod Fertil Dev. 2015 May 1. doi: 10.1071/RD14349. [Epub ahead of print] PubMed PMID: 25929179. 2: Chakraborty P, Roy SK. Effect of azaline B on follicular development and functions in the hamster. Mol Cell Endocrinol. 2015 Jan 15;400:1-9. doi: 10.1016/j.mce.2014.11.011. Epub 2014 Nov 24. PubMed PMID: 25462584; PubMed Central PMCID: PMC4274241. 3: Campen CA, Lai MT, Kraft P, Kirchner T, Phillips A, Hahn DW, Rivier J. Potent pituitary-gonadal axis suppression and extremely low anaphylactoid activity of a new gonadotropin releasing hormone (GnRH) receptor antagonist "azaline B". Biochem Pharmacol. 1995 May 11;49(9):1313-21. PubMed PMID: 7763313. 4: Rivier JE, Jiang G, Porter J, Hoeger CA, Craig AG, Corrigan A, Vale W, Rivier CL. Gonadotropin-releasing hormone antagonists: novel members of the azaline B family. J Med Chem. 1995 Jul 7;38(14):2649-62. PubMed PMID: 7629804. 5: Samant MP, Gulyas J, Hong DJ, Croston G, Rivier C, Rivier J. Synthesis, in vivo and in vitro biological activity of novel azaline B analogs. Bioorg Med Chem Lett. 2005 Jun 2;15(11):2894-7. PubMed PMID: 15911275. 6: Rivier J, Porter J, Hoeger C, Theobald P, Craig AG, Dykert J, Corrigan A, Perrin M, Hook WA, Siraganian RP, et al. Gonadotropin-releasing hormone antagonists with N omega-triazolylornithine, -lysine, or -p-aminophenylalanine residues at positions 5 and 6. J Med Chem. 1992 Nov 13;35(23):4270-8. PubMed PMID: 1280300. 7: Samant MP, Hong DJ, Croston G, Rivier C, Rivier J. Novel gonadotropin-releasing hormone antagonists with substitutions at position 5. Biopolymers. 2005;80(2-3):386-91. PubMed PMID: 15614806. 8: Rivier J, Theobald P, Porter J, Perrin M, Gunnet J, Hahn DW, Rivier C. Gonadotropin releasing hormone antagonists: novel structures incorporating N omega-cyano modified guanidine moieties. Biochem Biophys Res Commun. 1991 Apr 15;176(1):406-12. PubMed PMID: 1850267. 9: Jiang G, Stalewski J, Galyean R, Dykert J, Schteingart C, Broqua P, Aebi A, Aubert ML, Semple G, Robson P, Akinsanya K, Haigh R, Riviere P, Trojnar J, Junien JL, Rivier JE. GnRH antagonists: a new generation of long acting analogues incorporating p-ureido-phenylalanines at positions 5 and 6. J Med Chem. 2001 Feb 1;44(3):453-67. PubMed PMID: 11462984. 10: Zhu LJ, Hardy MP, Inigo IV, Huhtaniemi I, Bardin CW, Moo-Young AJ. Effects of androgen on androgen receptor expression in rat testicular and epididymal cells: a quantitative immunohistochemical study. Biol Reprod. 2000 Aug;63(2):368-76. PubMed PMID: 10906039. 11: Theobald P, Porter J, Rivier C, Corrigan A, Hook W, Siraganian R, Perrin M, Vale W, Rivier J. Novel gonadotropin-releasing hormone antagonists: peptides incorporating modified N omega-cyanoguanidino moieties. J Med Chem. 1991 Aug;34(8):2395-402. PubMed PMID: 1714956. 12: Tapanainen JS, Tilly JL, Vihko KK, Hsueh AJ. Hormonal control of apoptotic cell death in the testis: gonadotropins and androgens as testicular cell survival factors. Mol Endocrinol. 1993 May;7(5):643-50. PubMed PMID: 8316250. 13: Gobello C. Effects of GnRH antagonists vs agonists in domestic carnivores, a review. Reprod Domest Anim. 2012 Dec;47 Suppl 6:373-6. doi: 10.1111/rda.12025. Review. PubMed PMID: 23279542. 14: Jiang G, Miller C, Koerber SC, Porter J, Craig AG, Bhattacharjee S, Kraft P, Burris TP, Campen CA, Rivier CL, Rivier JE. Betidamino acid scan of the GnRH antagonist acyline. J Med Chem. 1997 Nov 7;40(23):3739-48. PubMed PMID: 9371239. 15: Samant MP, Gulyas J, Hong DJ, Croston G, Rivier C, Rivier J. Iterative approach to the discovery of novel degarelix analogues: substitutions at positions 3, 7, and 8. Part II. J Med Chem. 2005 Jul 28;48(15):4851-60. PubMed PMID: 16033265; PubMed Central PMCID: PMC2593149. 16: Rivier J, Jiang GC, Lahrichi SL, Porter J, Koerber SC, Rizo J, Corrigan A, Gierasch L, Hagler A, Vale W, Rivier C. Dose relationship between GnRH antagonists and pituitary suppression. Hum Reprod. 1996 Nov;11 Suppl 3:133-47. Review. PubMed PMID: 9147108. 17: Lunn SF, Recio R, Morris K, Fraser HM. Blockade of the neonatal rise in testosterone by a gonadotrophin-releasing hormone antagonist: effects on timing of puberty and sexual behaviour in the male marmoset monkey. J Endocrinol. 1994 Jun;141(3):439-47. PubMed PMID: 8071642. 18: Turnbull AV, Rivier C. Inhibition of gonadotropin-induced testosterone secretion by the intracerebroventricular injection of interleukin-1 beta in the male rat. Endocrinology. 1997 Mar;138(3):1008-13. PubMed PMID: 9048602. 19: Billig H, Furuta I, Rivier C, Tapanainen J, Parvinen M, Hsueh AJ. Apoptosis in testis germ cells: developmental changes in gonadotropin dependence and localization to selective tubule stages. Endocrinology. 1995 Jan;136(1):5-12. PubMed PMID: 7828558. 20: Broqua P, Riviere PJ, Conn PM, Rivier JE, Aubert ML, Junien JL. Pharmacological profile of a new, potent, and long-acting gonadotropin-releasing hormone antagonist: degarelix. J Pharmacol Exp Ther. 2002 Apr;301(1):95-102. PubMed PMID: 11907162.